Michelle Lytle is a Senior Director in Regulatory CMC for Biotechnology at Eli Lilly and Company. They previously held roles at Eli Lilly, including Principal Research Scientist and Analytical Development Scientist, where they provided leadership in regulatory strategies, analytical method development, and project oversight. Michelle’s career at Eli Lilly spanned from 2007 to 2021, with a focus on advancing pharmaceutical development through innovative analytical techniques. They earned a B.S. in Chemistry from Purdue University in 1992.
This person is not in the org chart
This person is not in any teams
This person is not in any offices